(Q37512560)

20 August 2017

1 reference

title

Translating genomics into clinical practice: applications in lung cancer (English)

1 reference

20 August 2017

0 references

1 reference

Aubrey Jolly Graham

1

1 reference

PubMed ID

19508830

20 August 2017

Anil Potti

series ordinal

2

1 reference

20 August 2017

1 July 2009

1 reference

20 August 2017

Current Oncology Reports

1 reference

20 August 2017

11

1 reference

20 August 2017

4

1 reference

20 August 2017

263-268

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-009-0037-z

20 August 2017

0 references

cites work

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

1 reference

12 December 2020

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

1 reference

12 December 2020

A gene expression signature predicts survival of patients with stage I non-small cell lung cancer

1 reference

12 December 2020

Cancer statistics, 1999.

1 reference

12 December 2020

Lung metastasis genes couple breast tumor size and metastatic spread.

1 reference

12 December 2020

The relationship between epidermal growth factor receptor mutations and clinicopathologic features in non-small cell lung cancers

1 reference

12 December 2020

Activating mutations in the tyrosine kinase domain of the epidermal growth factor receptor are associated with improved survival in gefitinib-treated chemorefractory lung adenocarcinomas.

1 reference

12 December 2020

A molecular signature of metastasis in primary solid tumors

1 reference

12 December 2020

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

Linking oncogenic pathways with therapeutic opportunities

1 reference

12 December 2020

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

1 reference

12 December 2020

The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

1 reference

12 December 2020

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

1 reference

12 December 2020

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

1 reference

12 December 2020

Global cancer statistics, 2002

1 reference

12 December 2020

Erlotinib in lung cancer - molecular and clinical predictors of outcome

1 reference

12 December 2020

Non-small cell lung cancer clinical practice guidelines in oncology

1 reference

12 December 2020

Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.

1 reference

12 December 2020

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

1 reference

12 December 2020

Customizing Cisplatin Based on Quantitative Excision Repair Cross-Complementing 1 mRNA Expression: A Phase III Trial in Non–Small-Cell Lung Cancer

1 reference

12 December 2020

Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline.

1 reference

12 December 2020

Utilization of genomic signatures to direct use of primary chemotherapy

1 reference

12 December 2020

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

1 reference

12 December 2020

1 reference

12 December 2020

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

1 reference

12 December 2020

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

1 reference

12 December 2020

Genomic signatures to guide the use of chemotherapeutics.

1 reference

12 December 2020

A genomic approach to identify molecular pathways associated with chemotherapy resistance

1 reference

12 December 2020

Lung cancer staging classification.

1 reference

12 December 2020

Mining gene expression profiles: expression signatures as cancer phenotypes

1 reference

12 December 2020

Erlotinib in previously treated non-small-cell lung cancer

1 reference

12 December 2020

Phase II study of pemetrexed in combination with carboplatin in the first-line treatment of advanced nonsmall cell lung cancer

1 reference

12 December 2020

Chips to bedside: incorporation of microarray data into clinical practice

1 reference

12 December 2020

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

1 reference

12 December 2020

Gene expression patterns that predict sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer cell lines and human lung tumors

1 reference

12 December 2020

A five-gene signature and clinical outcome in non-small-cell lung cancer

1 reference

12 December 2020

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

1 reference

12 December 2020

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer

1 reference

12 December 2020

10.1007/S11912-009-0037-Z

Identifiers

DOI

1 reference

20 August 2017

1 reference

PubMed ID

19508830